Neuronal hyperactivity - A key defect in Alzheimer's disease?

被引:166
|
作者
Busche, Marc Aurel [1 ,2 ,3 ,4 ]
Konnerth, Arthur [1 ,3 ,4 ]
机构
[1] Tech Univ Munich, Inst Neurosci, D-80290 Munich, Germany
[2] Tech Univ Munich, Dept Psychiat & Psychotherapy, D-80290 Munich, Germany
[3] Tech Univ Munich, Munich Cluster Syst Neurol SyNergy, D-80290 Munich, Germany
[4] Tech Univ Munich, Ctr Integrated Prot Sci CIPSM, D-80290 Munich, Germany
关键词
Alzheimer's disease; amyloid-ss; biomedicine; brain imaging; mouse models; neuronal dysfunction; neuronal hyperactivity; AMYLOID-BETA-PROTEIN; TRANSGENIC MOUSE MODELS; HIPPOCAMPAL ACTIVATION; PRECURSOR-PROTEIN; MEMORY DEFICITS; COGNITIVE IMPAIRMENTS; RELEASE PROBABILITY; HYPOTHETICAL MODEL; APOLIPOPROTEIN-E; UNIT-ACTIVITY;
D O I
10.1002/bies.201500004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Traditionally, the impairment of cognitive functions in Alzheimers disease (AD) is thought to result from a reduction in neuronal and synaptic activities, and ultimately cell death. Here, we review recent in vivo evidence from mouse models and human patients indicating that, particularly in early stages of AD, neuronal circuits are hyperactive instead of hypoactive. Functional analyses at many levels, from single neurons to neuronal populations to large-scale networks, with a variety of electrophysiological and imaging techniques have revealed two forms of AD-related hyperactivity and provided first insights into the synaptic mechanisms. The unexpected finding that hyperactivity is an early neuronal dysfunction represents a major conceptual shift in our understanding of AD that may have important implications for the development of therapeutic approaches.
引用
收藏
页码:624 / 632
页数:9
相关论文
共 50 条
  • [41] The cholinergic neuronal phenotype in alzheimer′s disease
    Jan Krzysztof Blusztajn
    Brygida Berse
    Metabolic Brain Disease, 2000, 15 (1) : 45 - 64
  • [42] The neuronal Shc adaptor in Alzheimer's Disease
    Triaca, Viviana
    Coccurello, Roberto
    Giacovazzo, Giacomo
    AGING-US, 2018, 10 (01): : 5 - 6
  • [43] Neuronal Calcium Signaling and Alzheimer's Disease
    Woods, Neha Kabra
    Padmanabhan, Jaya
    CALCIUM SIGNALING, 2012, 740 : 1193 - 1217
  • [44] Neuronal stem cells in Alzheimer's disease
    Kamphuis, W.
    Middeldorp, J.
    van Strien, M. E.
    Hol, E. M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S115 - S115
  • [45] Hemispatial visual defect in Alzheimer's disease
    Oda, Haruhiko
    Ohkawa, Shingo
    Maeda, Kiyoshi
    NEUROCASE, 2008, 14 (02) : 141 - 146
  • [46] Decreased amyloid-β and increased neuronal hyperactivity by immunotherapy in Alzheimer's models
    Marc Aurel Busche
    Christine Grienberger
    Aylin D Keskin
    Beomjong Song
    Ulf Neumann
    Matthias Staufenbiel
    Hans Förstl
    Arthur Konnerth
    Nature Neuroscience, 2015, 18 : 1725 - 1727
  • [47] Decreased amyloid-β and increased neuronal hyperactivity by immunotherapy in Alzheimer's models
    Busche, Marc Aurel
    Grienberger, Christine
    Keskin, Aylin D.
    Song, Beomjong
    Neumann, Ulf
    Staufenbiel, Matthias
    Foerstl, Hans
    Konnerth, Arthur
    NATURE NEUROSCIENCE, 2015, 18 (12) : 1725 - 1727
  • [48] Cholesterol: A Key in the Pathogenesis of Alzheimer's Disease
    Banerjee, Samya
    Mukherjee, Sanjoy
    CHEMMEDCHEM, 2018, 13 (17) : 1742 - 1743
  • [49] The key role of mitochondria in Alzheimer's disease
    Moreira, P. I.
    Cardoso, S. M.
    Santos, M. S.
    Oliveira, C. R.
    JOURNAL OF ALZHEIMERS DISEASE, 2006, 9 (02) : 101 - 110
  • [50] Key Peptides and Proteins in Alzheimer's Disease
    Penke, Botond
    Bogar, Ferenc
    Paragi, Gabor
    Gera, Janos
    Fulop, Livia
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2019, 20 (06) : 577 - 599